Nakhla A M, Bardin C W, Salomon Y, Mather J P, Jänne O A
Population Council, New York New York 10021.
J Androl. 1989 Jul-Aug;10(4):311-20. doi: 10.1002/j.1939-4640.1989.tb00110.x.
Studies demonstrating calcitonin receptors on Leydig cells have suggested that these cells may be one of the many sites affected by this peptide. To investigate this possibility, the effect of synthetic salmon calcitonin on the TM3 Leydig cell line (derived from immature mouse Leydig cells) and on primary Leydig cell-enriched preparations was examined. Synthetic salmon calcitonin stimulated the conversion of [3H]adenine to [3H]cyclic AMP in TM3 cells. In addition, the hormone stimulated the basal secretion of testosterone in both TM3 cell- and Leydig cell-enriched cultures and potentiated the action of hCG on Leydig cell-enriched cultures. Synthetic salmon calcitonin also increased the concentration of androgen and estrogen receptors in cultured TM3 Leydig cells by 2- and 4-fold, respectively, when added to the culture medium (1 micrograms/ml). The fact that 8-bromo-cyclic AMP decreased both androgen and estrogen receptor concentrations suggested that the effect of calcitonin on sex steroid receptors is not mediated by its effect on cyclic AMP in these cells. The possibility that the action of calcitonin on steroid receptors might be mediated by another messenger such as calcium (Ca2+) was therefore considered. Progressively lowering the concentration of Ca2+ in the culture medium of the cells from 1.5 mM to less than 0.01 mM decreased the concentration of both androgen and estrogen receptors. Returning the Ca2+ concentration to normal levels (1.5 mM) restored steroid receptor levels. Receptor levels were also decreased when the extracellular Ca2+ concentration was lowered to 0.5 mM, and treatment with the Ca2+ ionophore, A23187 (1 microM), restored receptor levels to normal. The calcium channel blocker, verapamil, decreased the androgen receptor concentration but unexpectedly increased the concentration of estrogen receptors. It was concluded that calcitonin stimulates cAMP formation and testosterone secretion, and increases the concentration of sex steroid receptors. These observations provide evidence that the previously demonstrated calcitonin receptors on Leydig cells may be coupled to several biologic responses in this cell type.
多项研究表明,睾丸间质细胞上存在降钙素受体,这提示这些细胞可能是受该肽影响的众多位点之一。为了探究这种可能性,研究人员检测了合成鲑鱼降钙素对TM3睾丸间质细胞系(源自未成熟小鼠睾丸间质细胞)以及对富含原代睾丸间质细胞的制剂的影响。合成鲑鱼降钙素刺激了TM3细胞中[3H]腺嘌呤向[3H]环磷酸腺苷的转化。此外,该激素刺激了TM3细胞和富含睾丸间质细胞的培养物中睾酮的基础分泌,并增强了人绒毛膜促性腺激素对富含睾丸间质细胞培养物的作用。当向培养基(1微克/毫升)中添加合成鲑鱼降钙素时,它还分别使培养的TM3睾丸间质细胞中的雄激素和雌激素受体浓度增加了2倍和4倍。8-溴环磷酸腺苷降低了雄激素和雌激素受体浓度,这一事实表明降钙素对性类固醇受体的作用并非通过其对这些细胞中环磷酸腺苷的影响来介导。因此,研究人员考虑了降钙素对类固醇受体的作用可能由另一种信使(如钙(Ca2+))介导的可能性。将细胞培养基中的Ca2+浓度从1.5毫摩尔逐渐降低至低于0.01毫摩尔,会降低雄激素和雌激素受体的浓度。将Ca2+浓度恢复到正常水平(1.5毫摩尔)可使类固醇受体水平恢复。当细胞外Ca2+浓度降至0.5毫摩尔时,受体水平也会降低,而用Ca2+离子载体A23187(1微摩尔)处理可使受体水平恢复正常。钙通道阻滞剂维拉帕米降低了雄激素受体浓度,但出人意料地增加了雌激素受体浓度。研究得出结论,降钙素刺激环磷酸腺苷的形成和睾酮的分泌,并增加性类固醇受体的浓度。这些观察结果提供了证据表明,先前在睾丸间质细胞上证明的降钙素受体可能与该细胞类型中的几种生物学反应相关联。